TT Capital Management LLC Makes New $504,000 Investment in Centene Corporation $CNC

TT Capital Management LLC bought a new stake in shares of Centene Corporation (NYSE:CNC) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 14,125 shares of the company’s stock, valued at approximately $504,000.

Several other large investors have also recently made changes to their positions in the company. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in Centene during the 3rd quarter worth $27,000. WPG Advisers LLC boosted its position in Centene by 44.5% during the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after acquiring an additional 282 shares during the last quarter. Bogart Wealth LLC grew its stake in Centene by 11,011.1% during the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock valued at $36,000 after acquiring an additional 991 shares in the last quarter. Financial Network Wealth Advisors LLC lifted its stake in Centene by 54.9% in the 3rd quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock worth $39,000 after purchasing an additional 390 shares in the last quarter. Finally, Quent Capital LLC acquired a new position in shares of Centene during the 3rd quarter worth approximately $45,000. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

Centene Stock Up 3.4%

Shares of CNC opened at $40.53 on Friday. The company’s 50-day moving average price is $42.13 and its 200 day moving average price is $36.37. Centene Corporation has a 12-month low of $25.08 and a 12-month high of $66.03. The company has a current ratio of 1.10, a quick ratio of 1.08 and a debt-to-equity ratio of 0.87. The firm has a market cap of $19.92 billion, a P/E ratio of -2.98, a price-to-earnings-growth ratio of 0.90 and a beta of 0.48.

Centene (NYSE:CNC) last announced its quarterly earnings results on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.22) by $0.03. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The business had revenue of $49.73 billion during the quarter, compared to analysts’ expectations of $48.41 billion. During the same period last year, the business earned $0.80 earnings per share. The business’s revenue for the quarter was up 21.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. On average, sell-side analysts forecast that Centene Corporation will post 6.86 earnings per share for the current year.

Analysts Set New Price Targets

CNC has been the topic of a number of analyst reports. Wells Fargo & Company set a $43.00 price objective on Centene and gave the stock an “equal weight” rating in a research report on Wednesday, January 7th. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $38.00 target price (up from $33.00) on shares of Centene in a research note on Thursday, October 30th. Barclays set a $44.00 price target on shares of Centene and gave the company an “equal weight” rating in a research report on Tuesday, November 4th. Mizuho set a $47.00 price objective on shares of Centene in a research report on Friday, January 9th. Finally, Wall Street Zen lowered shares of Centene from a “buy” rating to a “hold” rating in a report on Sunday. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $41.81.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.